Spectrum Pharma (SPPI) Tops Q4 EPS by 17c

March 8, 2017 4:05 PM EST

Spectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of ($0.10), $0.17 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $31.13 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings